OXFYY (Oxford Nanopore Technologies) Days Payable: 217.56 (As of Dec. 2025) — 74% Above Median


OXFYY Oxford Nanopore Technologies PLC OXFYY
50 GF Score
Price $6.50
GF Value $9.79
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Oxford Nanopore Technologies Days Payable?

Oxford Nanopore Technologies OXFYY -11.92% 50 Days Payable is 217.56 as of Dec. 2025, which is 74% above its 10-year median of 124.78. GuruFocus rates OXFYY with a GF Score™ of 50/100 and a GF Value™ of $9.79 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 707 Biotechnology companies, Oxford Nanopore Technologies ranks better than 62.38% on this metric.

Oxford Nanopore Technologies's average Accounts Payable for the six months ended in Dec. 2025 was $77.2 Mil. Oxford Nanopore Technologies's Cost of Goods Sold for the six months ended in Dec. 2025 was $64.8 Mil. Hence, Oxford Nanopore Technologies's Days Payable for the six months ended in Dec. 2025 was 217.56.

The historical rank and industry rank for Oxford Nanopore Technologies's Days Payable or its related term are showing as below:

OXFYY' s Days Payable Range Over the Past 10 Years
Min: 97.95   Med: 124.78   Max: 232.85
Current: 191.04

During the past 8 years, Oxford Nanopore Technologies's highest Days Payable was 232.85. The lowest was 97.95. And the median was 124.78.

OXFYY's Days Payable is ranked better than
62.38% of 707 companies
in the Biotechnology industry
Industry Median: 113.76 vs OXFYY: 191.04

Oxford Nanopore Technologies's Days Payable declined from Dec. 2024 (258.64) to Dec. 2025 (217.56). It may suggest that Oxford Nanopore Technologies accelerated paying its suppliers.


Oxford Nanopore Technologies Days Payable Historical Data

* Premium members only.

The historical data trend for Oxford Nanopore Technologies's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxford Nanopore Technologies Days Payable Chart

Oxford Nanopore Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial 156.42 110.95 109.27 132.57 94.52

Oxford Nanopore Technologies Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 209.76 304.94 258.64 257.78 217.56

OXFYY vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Oxford Nanopore Technologies's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Nanopore Technologies Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Nanopore Technologies's Days Payable distribution charts can be found below:

* The bar in red indicates where Oxford Nanopore Technologies's Days Payable falls into.


OXFYY
50GF Score
Oxford Nanopore Technologies PLC OXFYY
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oxford Nanopore Technologies Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Oxford Nanopore Technologies's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (39.57 + 24.632) / 2 ) / 123.962*365
=32.101 / 123.962*365
=94.52

Oxford Nanopore Technologies's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

Days Payable (Q: Dec. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2025 ) + Accounts Payable (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (129.851 + 24.632) / 2 ) / 64.793*365 / 2
=77.2415 / 64.793*365 / 2
=217.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 217.56 mean?
Oxford Nanopore Technologies (OXFYY) has a Days Payable of 217.56 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Oxford Nanopore Technologies and its competitors. This is 74% above median its historical median of 124.78. Over the past decade, Oxford Nanopore Technologies' Days Payable has ranged from 97.95 to 232.85. According to the industry distribution chart, Oxford Nanopore Technologies ranks #266 out of 707 companies in the Biotechnology industry, placing it in the top 37.6%.
Is Oxford Nanopore Technologies' Days Payable too high?
Oxford Nanopore Technologies' current Days Payable of 217.56 is 74% above median its 10-year median of 124.78. Over the past 10 years, this metric has ranged from a low of 97.95 to a high of 232.85. The Biotechnology industry median Days Payable is 113.76. Oxford Nanopore Technologies' value of 217.56 is 91.2% above this industry median. Based on the distribution chart, Oxford Nanopore Technologies ranks #266 out of 707 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Oxford Nanopore Technologies has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Oxford Nanopore Technologies' Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Oxford Nanopore Technologies ranks #266 out of 707 companies for Days Payable. This puts Oxford Nanopore Technologies in the upper half of its industry. The industry median Days Payable is 113.76. Oxford Nanopore Technologies' value of 217.56 is 91.2% above this benchmark. Historically, Oxford Nanopore Technologies' own Days Payable has ranged from 97.95 to 232.85 over the past decade. While the company's 10-year median is 124.78 vs. the industry median of 113.76, Oxford Nanopore Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.76, based on 707 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oxford Nanopore Technologies's current Days Payable of 217.56 is 91.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Oxford Nanopore Technologies and its competitors. For the Biotechnology industry, the median Days Payable is 113.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oxford Nanopore Technologies's current Days Payable is 217.56, which is 74% above median its own 10-year median of 124.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxford Nanopore Technologies stock overvalued right now?
Based on GuruFocus' analysis, Oxford Nanopore Technologies (OXFYY) is currently considered Significantly Undervalued. The stock's GF Value™ is $9.79, compared to a current price of $6.50 — trading 33.6% below its estimated fair value. The current Days Payable is 217.56, which is 74% above median its 10-year median of 124.78 and 91.2% above the Biotechnology industry median of 113.76. Oxford Nanopore Technologies' overall GF Score™ is 50/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Oxford Nanopore Technologies (OXFYY), the current Days Payable is 217.56 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oxford Nanopore Technologies (OXFYY) Overvalued in 2026?

Based on GuruFocus' analysis, Oxford Nanopore Technologies stock appears to be undervalued. The current stock price of $6.50 is trading 33.6% below its estimated GF Value™ of $9.79. GuruFocus considers Oxford Nanopore Technologies to be Significantly Undervalued.

Key valuation signals for OXFYY:

  • Days Payable: 217.56 (74% above median its 10-year median of 124.78)
  • GF Value™: $9.79 vs. price of $6.50 (33.6% below fair value)
  • GF Score™: 50/100 with 2 warning signs
  • Industry Position: 91.2% above the Biotechnology median (#266 of 707)

No single metric tells the full story. See the OXFYY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Oxford Nanopore Technologies Business Description

Address Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX4 4DQ
Oxford Nanopore Technologies PLC is involved in researching, developing, manufacturing and commercializing deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that provides rich data, is fast, accessible and easy to use, and which allows the real-time analysis of DNA or RNA. It has developed and brought to market a new generation molecular sensing platform based on nanopores. The first application is DNA/RNA sequencing and the platform is also being developed for the analysis of proteins and metabolites. It operates in single segment of providing products and services related to the sale and use of its nanopore-based sensing technology. Geographically its operations are spread across EMES, AMR, and APAC.
50GF Score

Get the complete analysis for OXFYY

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.50
Price
$9.79
GF Value